中国糖尿病领域新挑战(英文).pptVIP

The Rising Challenge of Diabetes in China Chang Yu Pan Department of Endocrinology, Chinese PLA General Hospital Chinese PLA Endocrinology and Metabolism Centre and Key Laboratory Apr.11- 2008 Prevalence of overweight / obesity in China (20-70 years) Prevalence of overweight/obesity in Chinese children adolescents (2002) Prevalence of overweight/obesity in Chinese children adolescents (1985- 2000) Global prevalence of diabetes * In 2007, the five countries with the largest numbers of people with diabetes are: India, China, United States, Russia, Germany By 2025, the largest increases in diabetes prevalence will occur in low- and middle-income countries Each year an additional 7 million people worldwide develop diabetes Growing prevalence of diabetes and prediabetes in China Prevalence of IGT in all age groups was higher than that of Diabetes Total prevalence of newly diagnosed DM:4.9% China Heart Survey – dysglycemia is common in patients with CAD Chinese IGT population is at high risk of DM IGT and Atherosclerosis - Study from PLA General Hospital in China The cumulative rate of CVD CODIC2Control of Type 2 Diabetes in China Surveillance of Type 2 Diabetes in China BMI WAIST MEAN HbA1c LEVELS LIPID PROFILES Type of Treatment for Dyslipidaemia HYPERTENSION+ METABOLIC SYNDROME About 55% DM outpatients have complications Global cost of diabetes* Economic and societal costs mainly arise from complications of diabetes Economic consequences result largely from: Cost of care Loss of productivity due to disability and premature death In 2007, global health expenditures to treat and prevent diabetes total at least US $232 billion Total Direct Medical Cost of treating Type 2 DM in urban China Direct Medical Cost for patients with Diabetes in China Effect of complications on costs CHD deaths than expected from baseline mortality rates Diabetes mortality continues  its steady escalation Cause of death in China Motality of Diabetes